Growth Metrics

Omeros (OMER) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 48.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 48.77%
Dec 31, 2025 7.29%
Sep 30, 2025 39.03%
Jun 30, 2025 9.28%
Mar 31, 2025 1.66%
Dec 31, 2024 31.19%
Sep 30, 2024 -17.80%
Jun 30, 2024 -8.83%
Mar 31, 2024 4.40%
Dec 31, 2023 20.92%
Sep 30, 2023 -3.70%
Jun 30, 2023 -9.59%
Mar 31, 2023 -10.29%
Dec 31, 2022 25.62%
Sep 30, 2022 -49.30%
Jun 30, 2022 -41.02%
Mar 31, 2022 -16.72%
Dec 31, 2021 -64.50%
Sep 30, 2021 17.23%
Jun 30, 2021 -13.79%
Mar 31, 2021 -18.04%
Dec 31, 2020 -72.87%
Sep 30, 2020 -80.39%
Jun 30, 2020 -31.92%
Mar 31, 2020 -24.34%
Dec 31, 2019 -98.48%
Sep 30, 2019 -5.12%
Jun 30, 2019 -5.16%
Mar 31, 2019 -6.05%
Dec 31, 2018 -7.82%
Sep 30, 2018 -25.68%
Jun 30, 2018 -26.59%
Mar 31, 2018 -17.34%
Dec 31, 2017 6.97%
Sep 30, 2017 24.14%
Jun 30, 2017 6.87%
Mar 31, 2017 2.01%
Dec 31, 2016 -0.91%
Sep 30, 2016 -0.35%
Jun 30, 2016 2.39%
Mar 31, 2016 -25.24%
Dec 31, 2015 -33.66%
Sep 30, 2015 -14.51%
Jun 30, 2015 -24.83%
Mar 31, 2015 -30.22%
Dec 31, 2014 -26.70%
Sep 30, 2014 -39.32%
Jun 30, 2014 -49.23%
Mar 31, 2014 -34.47%
Dec 31, 2013 -16.32%
Sep 30, 2013 -21.89%
Jun 30, 2013 -19.67%